Effect of revascularization on left ventricular remodeling in patients with heart failure from severe chronic ischemic left ventricular dysfunction

American Journal of Cardiology

Volumn 88, Issue 6, 2001, Pages 624-629

  Senior, Roxy ^a,c   Lahiri, Avijit ^a   Kaul, Sanjiv ^b  

^a ST MARK S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF VIRGINIA   (United States)

^c NORTHWICK PARK HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; GEOMETRY; HEART EJECTION FRACTION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE; HEART MUSCLE REVASCULARIZATION; HEART SURGERY; HEART VENTRICLE REMODELING; HUMAN; ISCHEMIC HEART DISEASE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; SURVIVAL; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

COHORT STUDIES; CORONARY ANGIOGRAPHY; ECHOCARDIOGRAPHY; ENGLAND; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; MYOCARDIAL REVASCULARIZATION; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 0035884861     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(01)01803-3     Document Type: Article

References (30)

1. Dobutamine echocardiography and thallium-201 imaging predict functional improvement after revascularization in severe ischaemic left ventricular dysfunction
2. Head-to-head comparison of exercise-redistribution-reinjection thallium single-photon emission computed tomography and low dose dobutamine echocardiography for prediction of reversibility of chronic left ventricular ischemic dysfunction
3. Echocardiography during infusion of dobutamine for identification of reversible dysfunction in patients with chronic coronary artery disease
4. Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularization
5. There may be more to myocardial viability than meets the eye!
6. Myocardial viability on echocardiography predicts long-term survival in patients with ischemic congestive heart failure
7. Prognostic value of dobutamine echocardiography in patients with left ventricular dysfunction
8. Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular dysfunction
9. Prognostic value of the amount of dysfunctional but viable myocardium in revascularized patients with coronary artery disease and left ventricular dysfunction
10. Assessment of left ventricular ejection fraction and volumes by real-time, two-dimensional echocardiography. A comparison of cineangiographic and radionuclide techniques
11. Anatomic validation of left ventricular mass estimates from clinical two-dimensional echocardiography: Initial results
12. Left ventricular shape, afterload and survival in idiopathic dilated cardiomyopathy
13. Low-dose dobutamine echocardiography detects reversible dysfunction after thrombolytic therapy of acute myocardial infarction
14. The response of the dysfunctional myocardium to dobutamine: "The Eyes See What the Mind Knows!"
15. Logistic regression in survival analysis
16. On the use of repeated measurements in regression analysis with dichotomous responses
17. Regression models and life tables
18. Nonparametric estimation from incomplete observations
19. Direct measurement of inner and outer wall thickening dynamics with epicardial echocardiography
20. Dobutamine echocardiography for determining the extent of myocardial salvage after reperfusion: An experimental evaluation
21. Contractile versus microvascular reserve for the determination of the extent of myocardial salvage after reperfusion: The effect of residual stenosis
22. 201tl imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary artery bypass surgery in patients with severely depressed left ventricular function
23. Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability
24. Microvascular integrity indicates myocellular viability in patients with recent myocardial infarction: New insights using myocardial contrast echocardiography
25. A canine model of chronic ischemic cardiomyopathy: Characterization of regional flow-function relations
26. Mechanism of ischemic mitral regurgitation: An experimental evaluation
27. Mechanism of mitral leaflet excursion
28. The uses and limitations of end-systolic indices of left ventricular function
29. The effect of carvedilol on left ventricular mass, chamber geometry and mitral regurgitation in chronic heart failure
30. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure